HOME >> MEDICINE >> NEWS
Aromatase inhibitors: A promising new treatment for endometriosis

Letrozole (Femara), an aromatase inhibitor currently used to prevent breast cancer recurrence in postmenopausal women, shows promise in the treatment of endometriosis, according to the results of a pioneering pilot study conducted by Serdar Bulun, M.D., chief of the Division of Reproductive Biology Research at Northwestern Memorial Hospital. His findings were published in the February issue of Fertility and Sterility.

"This study demonstrates the potential of aromatase inhibitors to significantly and rapidly reduce disease severity and pain, offering women a new and more effective way of suppressing endometriosis with fewer side effects," explains Dr. Bulun. "Endometriosis is caused when tissue similar to the lining of the uterus grows elsewhere in the body and affects about 10 to 15 percent of women of reproductive age. It causes chronic pelvic pain and contributes to infertility."

Within the past 10 years, the research team led by Dr. Bulun pioneered the molecular model that the aromatase enzyme, which produces estrogen, is present in the endometrial tissue of women with endometriosis. His team discovered that this enzyme is able to reproduce itself, creating a vicious cycle of estrogen production.

"This explains why despite surgery, hormone treatments and hysterectomies, many women continue to suffer with symptoms of endometriosis," explains Dr. Bulun. "Endometriosis is an estrogen-dependent disease, so estrogen for endometriosis is like fuel for fire. We need to attack the root problem the aromatase in order to eliminate this cycle, halt the local production of estrogen and treat women with this disease."

Dr. Bulun evaluated 10 patients with moderate to severe endometriosis, all previously treated both medically and surgically with unsatisfactory results. Each of these patients took letrozole, along with progestin, for six months. Dr. Bulun evaluated the endometriosis objectively by performing laparoscop
'"/>

Contact: Patty Keiler
pkeiler@nmh.org
312-926-5900
Northwestern Memorial Hospital
13-Feb-2004


Page: 1 2

Related medicine news :

1. Aromatase inhibitors should be first-line treatment for certain type of breast cancer
2. HIV-1 protease inhibitors: Effective against malaria?
3. Another look finds promising proteomics test is not biologically plausible
4. Inflammatory cells highly promising target in NF 1
5. Drug treatment promising for halting Huntingtons-related nerve death
6. Triple-drug therapy promising against African HIV subtype
7. Mayo Clinic researchers announce promising next generation treatments for multiple myeloma
8. Outpatient lung cancer procedure promising for inoperable disease
9. PET scanning promising in diagnosing cancer-related neurological disorders
10. Preliminary results are promising in Alzheimers gene therapy trial
11. Fertility herbal supplement sprouts promising results in Stanford pilot study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/18/2019)... ... , ... HR Maximizer Inc ( https://hrmaximizer.com ) announced today ... Healthcare HR Association (HHHRA - https://hhhra.org ). In addition to having ... PageUp, CRC, Alliance Work Partners and Kognito. , Houston Healthcare HR Association, The ...
(Date:6/16/2019)... , ... June 15, 2019 , ... Convoy of Hope ... has been committed to helping those in need around the world. To date, Convoy ... than 125 countries. Convoy’s work would not be possible without the dedication and generosity ...
(Date:6/13/2019)... DETROIT (PRWEB) , ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease ... , Painful periods , Heavy bleeding , ... Constipation , Women’s Excellence uses the latest and newest treatment protocols in ...
(Date:6/13/2019)... ... June 13, 2019 , ... Pure Ratios, the ... cannabis delivery company, Driven Deliveries, Inc., the only publicly traded cannabis delivery service ... the population of California with overnight cannabis delivery to major thriving markets such ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... Clinical ... experience, is pleased to announce that Jonathan Andrus , chief business officer at ... by the Duke-Margolis Center for Health Policy on July 1, 2019, in ...
Breaking Medicine News(10 mins):
(Date:6/14/2019)... (PRWEB) , ... June 14, 2019 , ... ... National Cyclotron and PET Centre, Chulabhorn Hospital announced today a research collaboration to ... of aging Thai individuals. The first subjects have been recruited and imaged. LMI ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... ... as a Prime awardee of the Network of Quality Improvement and Innovation Contractor. ... five years. As a Prime NQIIC awardee partnering with other Quality Improvement ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... has announced the new Smart Scheduling product, part of the HCHB Intelligence Suite, ... Scheduling product uses complex algorithms to create highly efficient routing, mapping and scheduling ...
Breaking Medicine Technology:
Cached News: